186 related articles for article (PubMed ID: 32014856)
21. Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes.
Keppler-Noreuil KM; Burton-Akright J; Lindhurst MJ; Shwetar J; Sapp JC; Darling T; Biesecker LG
Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31371346
[TBL] [Abstract][Full Text] [Related]
22. Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.
Modlin EW; Slavotinek AM; Darling TN; Lipkowitz S; Barr FG; Munster PN; Biesecker LG; Ours CA
Am J Med Genet A; 2022 Sep; 188(9):2766-2771. PubMed ID: 35441778
[TBL] [Abstract][Full Text] [Related]
23. Prenatal diagnosis of Proteus syndrome: Diagnosis of an AKT1 mutation from amniocytes.
Abell K; Tolusso L; Smith N; Hopkin R; Vawter-Lee M; Habli M; Riddle S; Calvo-Garcia MA; Guan Q; Bierbrauer K; Hwa V; Saal HM
Birth Defects Res; 2020 Nov; 112(19):1733-1737. PubMed ID: 32935482
[TBL] [Abstract][Full Text] [Related]
24. Proteus syndrome: a natural clinical course of Proteus syndrome.
Linton JA; Seo BK; Oh CS
Yonsei Med J; 2002 Apr; 43(2):259-66. PubMed ID: 11971221
[TBL] [Abstract][Full Text] [Related]
25. Hypertrichotic patches as a mosaic manifestation of Proteus syndrome.
Pithadia DJ; Roman JW; Sapp JC; Biesecker LG; Darling TN
J Am Acad Dermatol; 2021 Feb; 84(2):415-424. PubMed ID: 32035943
[TBL] [Abstract][Full Text] [Related]
26. A mouse model of Proteus syndrome.
Lindhurst MJ; Brinster LR; Kondolf HC; Shwetar JJ; Yourick MR; Shiferaw H; Keppler-Noreuil KM; Elliot G; Rivas C; Garrett L; Gomez-Rodriguez J; Sebire NJ; Hewitt SM; Schwartzberg PL; Biesecker LG
Hum Mol Genet; 2019 Sep; 28(17):2920-2936. PubMed ID: 31194862
[TBL] [Abstract][Full Text] [Related]
27. A dyadic genotype-phenotype approach to diagnostic criteria for Proteus syndrome.
Sapp JC; Buser A; Burton-Akright J; Keppler-Noreuil KM; Biesecker LG
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):565-570. PubMed ID: 31692258
[TBL] [Abstract][Full Text] [Related]
28. Radiologic manifestations of Proteus syndrome.
Jamis-Dow CA; Turner J; Biesecker LG; Choyke PL
Radiographics; 2004; 24(4):1051-68. PubMed ID: 15256628
[TBL] [Abstract][Full Text] [Related]
29. Proteus syndrome: a case report.
Pangkanon S; Limpongsanurak W; Sangtawesin V
J Med Assoc Thai; 2001 May; 84(5):730-4. PubMed ID: 11560226
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.
Lapierre JM; Eathiraj S; Vensel D; Liu Y; Bull CO; Cornell-Kennon S; Iimura S; Kelleher EW; Kizer DE; Koerner S; Makhija S; Matsuda A; Moussa M; Namdev N; Savage RE; Szwaya J; Volckova E; Westlund N; Wu H; Schwartz B
J Med Chem; 2016 Jul; 59(13):6455-69. PubMed ID: 27305487
[TBL] [Abstract][Full Text] [Related]
31. Periodontal findings and other oral manifestations in Proteus syndrome: a case report.
Canabarro A; Galheigo TM; Galheigo de Oliveira e Silva D; Tinoco EM
Quintessence Int; 2008 Apr; 39(4):307-11. PubMed ID: 19081899
[TBL] [Abstract][Full Text] [Related]
32. Monozygotic twins discordant for Proteus syndrome.
Brockmann K; Happle R; Oeffner F; König A
Am J Med Genet A; 2008 Aug; 146A(16):2122-5. PubMed ID: 18627057
[TBL] [Abstract][Full Text] [Related]
33. Proteus syndrome: an update.
Cohen MM
Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):38-52. PubMed ID: 16010681
[TBL] [Abstract][Full Text] [Related]
34. AKT Inhibition in Solid Tumors With AKT1 Mutations.
Hyman DM; Smyth LM; Donoghue MTA; Westin SN; Bedard PL; Dean EJ; Bando H; El-Khoueiry AB; Pérez-Fidalgo JA; Mita A; Schellens JHM; Chang MT; Reichel JB; Bouvier N; Selcuklu SD; Soumerai TE; Torrisi J; Erinjeri JP; Ambrose H; Barrett JC; Dougherty B; Foxley A; Lindemann JPO; McEwen R; Pass M; Schiavon G; Berger MF; Chandarlapaty S; Solit DB; Banerji U; Baselga J; Taylor BS
J Clin Oncol; 2017 Jul; 35(20):2251-2259. PubMed ID: 28489509
[TBL] [Abstract][Full Text] [Related]
35. Proteus Syndrome: A Rare Disease Of Disproportionate And Asymmetric Overgrowth Of Connective Tissue.
Qaisar F; Butt NI; Ajmal Ghoauri MS; Azhar M; Javed MU; Samad A
J Ayub Med Coll Abbottabad; 2023; 35(1):177-179. PubMed ID: 36849404
[TBL] [Abstract][Full Text] [Related]
36. Early Recognition of Proteus Syndrome.
Rodenbeck DL; Greyling LA; Anderson JH; Davis LS
Pediatr Dermatol; 2016 Sep; 33(5):e306-10. PubMed ID: 27378680
[TBL] [Abstract][Full Text] [Related]
37. Severe gynaecological involvement in Proteus Syndrome.
Severino-Freire M; Maza A; Kuentz P; Duffourd Y; Faivre L; Brazet E; Chassaing N; Mery-Lemarche E; Vabres P; Mazereeuw-Hautier J
Eur J Med Genet; 2019 Apr; 62(4):270-272. PubMed ID: 30103035
[TBL] [Abstract][Full Text] [Related]
38. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
[TBL] [Abstract][Full Text] [Related]
39. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases.
Turner JT; Cohen MM; Biesecker LG
Am J Med Genet A; 2004 Oct; 130A(2):111-22. PubMed ID: 15372514
[TBL] [Abstract][Full Text] [Related]
40. Proteus syndrome caused by novel somatic AKT1 duplication.
AlAnzi T; Al-Mashharawi E; Alhashem A
Saudi Med J; 2021 Jan; 42(1):95-99. PubMed ID: 33399177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
